Forbes India Cover Story # 254: The race to make a covid 19 vaccine in India

It typically takes five years and about Rs 15 crore for just the first of many phases to introduce a viable vaccine to market. Companies across India such as Zydus Cadila, Serum Institute and Bharat Biotech are working against the clock to shrink this period down to a few months. In this episode Forbes Indias Divya Shekhar takes a deep dive into what this rush looks like on the ground and gives us a glimpse into the path ahead. Podcast produced in association with theindicast.com<img src="http://feeds.feedburner.com/~r/ForbesIndia/~4/kjXaVirJDBg" height="1" width="1" alt=""/>